Srijanee Das

1.1k total citations · 1 hit paper
8 papers, 653 citations indexed

About

Srijanee Das is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Srijanee Das has authored 8 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Srijanee Das's work include HIV Research and Treatment (3 papers), Hepatitis B Virus Studies (3 papers) and Hepatitis C virus research (3 papers). Srijanee Das is often cited by papers focused on HIV Research and Treatment (3 papers), Hepatitis B Virus Studies (3 papers) and Hepatitis C virus research (3 papers). Srijanee Das collaborates with scholars based in United States, India and Australia. Srijanee Das's co-authors include Benson Edagwa, Howard E. Gendelman, Mahmudul Hasan, Jonathan Herskovitz, Chamindie Punyadeera, Milankumar Patel, Wilson R. Blomberg, St Patrick Reid, Ahmed M. Senan and Robert Eisenberg and has published in prestigious journals such as Nature Materials, Advanced Drug Delivery Reviews and Science Advances.

In The Last Decade

Srijanee Das

8 papers receiving 642 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostics for SARS-CoV-2 infections

2021 585 citations Bhavesh D. Kevadiya, Jatin Machhi et al. Nature Materials profile →

Peers

Srijanee Das

ID

BE

MB

EPIDE

RNMI

Dhruvkumar Soni United States

Danrong Shi China

Wilson R. Blomberg United States

Benoît Kabamba‐Mukadi Belgium

Ekawat Pasomsub Thailand

Connie Le Canada

Christof Jungbauer Austria

Yanhong Sun China

Stephen N. Crooke United States

Dhruvkumar Soni United States

Srijanee Das

435 ×1.0

ID

318 ×1.0

BE

293 ×1.1

MB

52 ×0.8

EPIDE

39 ×1.1

RNMI

Citations per year, relative to Srijanee Das Srijanee Das (= 1×) peers Dhruvkumar Soni

Countries citing papers authored by Srijanee Das

Since Specialization

Citations

This map shows the geographic impact of Srijanee Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srijanee Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srijanee Das more than expected).

Fields of papers citing papers by Srijanee Das

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srijanee Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srijanee Das. The network helps show where Srijanee Das may publish in the future.

Co-authorship network of co-authors of Srijanee Das

This figure shows the co-authorship network connecting the top 25 collaborators of Srijanee Das. A scholar is included among the top collaborators of Srijanee Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srijanee Das. Srijanee Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Das, Srijanee, Haritha Chava, Weimin Wang, et al.. (2025). A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression. Science Advances. 11(31). eadw2286–eadw2286. 1 indexed citations

2.

Islam, Farhana, Srijanee Das, Md Ashaduzzaman, et al.. (2024). Development of an extended action fostemsavir lipid nanoparticle. Communications Biology. 7(1). 917–917. 3 indexed citations

3.

Sillman, Brady, Mahmudul Hasan, Srijanee Das, et al.. (2023). Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection. Advanced Drug Delivery Reviews. 200. 115009–115009. 24 indexed citations

4.

Das, Srijanee, et al.. (2023). Chronic Hepatitis B Infection: New Approaches towards Cure. Biomolecules. 13(8). 1208–1208. 15 indexed citations

5.

Das, Srijanee, Weimin Wang, Murali Ganesan, et al.. (2022). An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science Advances. 8(51). eade9582–eade9582. 11 indexed citations

6.

Kevadiya, Bhavesh D., Jatin Machhi, Jonathan Herskovitz, et al.. (2021). Pharmacotherapeutics of SARS-CoV-2 Infections. Journal of Neuroimmune Pharmacology. 16(1). 12–37. 5 indexed citations

7.

Kevadiya, Bhavesh D., Jatin Machhi, Jonathan Herskovitz, et al.. (2021). Diagnostics for SARS-CoV-2 infections. Nature Materials. 20(5). 593–605. 585 indexed citations breakdown →

8.

Patel, Milankumar, Farah Shahjin, Mahmudul Hasan, et al.. (2021). The Immunopathobiology of SARS-CoV-2 Infection. FEMS Microbiology Reviews. 45(6). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact